Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1987 1
1988 1
1995 1
1999 1
2000 7
2001 1
2002 1
2003 4
2004 10
2005 11
2006 16
2007 22
2008 27
2009 42
2010 41
2011 71
2012 67
2013 82
2014 81
2015 101
2016 99
2017 155
2018 150
2019 160
2020 205
2021 294
2022 286
2023 312
2024 413
2025 65

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,365 results

Results by year

Filters applied: . Clear all
Page 1
Acute effects of different "exercise snacking'' modalities on glycemic control in patients with type 2 diabetes mellitus (T2DM): study protocol for a randomized controlled trial.
Lazić A, Danković G, Korobeinikov G, Cadenas-Sanchez C, Trajković N. Lazić A, et al. BMC Public Health. 2025 Feb 11;25(1):566. doi: 10.1186/s12889-025-21669-9. BMC Public Health. 2025. PMID: 39934727
BACKGROUND: Impaired glycemic control, a sedentary lifestyle and diabetes related consequences are common challenges faced by experts and individuals with type 2 diabetes mellitus (T2DM). Although regular exercise has been shown to improve glycemic control in indivi …
BACKGROUND: Impaired glycemic control, a sedentary lifestyle and diabetes related consequences are common challenges faced by experts and in …
Continuous glucose monitoring-derived time in range and CV are associated with elevated risk of adverse kidney outcomes for patients with type 2 diabetes.
Zhang Q, Xiao S, Zou F, Jiao X, Shen Y. Zhang Q, et al. Diabetes Metab. 2025 Feb 9:101616. doi: 10.1016/j.diabet.2025.101616. Online ahead of print. Diabetes Metab. 2025. PMID: 39933649
Current guidelines recommend assessing glycemic control using continuous glucose monitoring (CGM), which provides a comprehensive glycemic profile to supplement HbA1c measurement. ...This retrospective cohort study included 1274 patients with type 2
Current guidelines recommend assessing glycemic control using continuous glucose monitoring (CGM), which provides a com …
Continuous Feeding Insulin Injection (CFII): A New Simple Method to Stabilize Severe Glucose Variability and Nutrition Delivery in Critically Ill Patients.
Ohshiro Y. Ohshiro Y. Cureus. 2025 Feb 9;17(2):e78758. doi: 10.7759/cureus.78758. eCollection 2025 Feb. Cureus. 2025. PMID: 39931500 Free PMC article.
CFII integrates two key components: continuous enteral nutrition (CEN) delivered at a fixed rate over 24 hours, based on the patient's metabolic needs, and continuous insulin infusion dynamically adjusted according to frequent or continuous blood glucose monitori
CFII integrates two key components: continuous enteral nutrition (CEN) delivered at a fixed rate over 24 hours, based on the patient's metab …
Characterizing insulin dosing behaviour and glycaemic excursions: Development of metrics using connected insulin pen and continuous glucose monitoring.
Wolpert H, Rodbard D, Xue J, Johnson J, Dassau E. Wolpert H, et al. Diabetes Obes Metab. 2025 Feb 10. doi: 10.1111/dom.16249. Online ahead of print. Diabetes Obes Metab. 2025. PMID: 39930566
We describe two algorithms for detecting glucose excursions using continuous glucose monitoring (CGM) data and then link excursions to CIP data to derive "insulin metrics" characterizing suboptimal bolus dosing practices. MATERIALS AND METHODS: This post hoc …
We describe two algorithms for detecting glucose excursions using continuous glucose monitoring (CGM) data and then lin …
The Utility of Smart Multiple Daily Injection Systems in Intensive Insulin-Treated People With Diabetes: An Italian Expert Consensus.
Giorgino F, Bonfanti R, Castaldo F, Irace C, Laurenzi A, Maffeis C, Pappagallo G, Pitocco D, Rabbone I, Zarra E, Scaramuzza AE. Giorgino F, et al. J Diabetes Sci Technol. 2025 Feb 10:19322968251316577. doi: 10.1177/19322968251316577. Online ahead of print. J Diabetes Sci Technol. 2025. PMID: 39927665 Review.
BACKGROUND: Smart systems for multiple daily injections (Smart MDI) integrate continuous glucose monitoring, connected insulin pens, smartphone apps, and cloud-based data storage to provide bolus and corrective dose suggestions, reminders/alerts, automatic tr …
BACKGROUND: Smart systems for multiple daily injections (Smart MDI) integrate continuous glucose monitoring, connected …
Cross-sectional design and protocol for Artificial Intelligence Ready and Equitable Atlas for Diabetes Insights (AI-READI).
Owsley C, Matthies DS, McGwin G, Edberg JC, Baxter SL, Zangwill LM, Owen JP, Lee CS; AI-READI Consortium. Owsley C, et al. BMJ Open. 2025 Feb 6;15(2):e097449. doi: 10.1136/bmjopen-2024-097449. BMJ Open. 2025. PMID: 39915016 Free PMC article.
INTRODUCTION: Artificial Intelligence Ready and Equitable for Diabetes Insights (AI-READI) is a data collection project on type 2 diabetes mellitus (T2DM) to facilitate the widespread use of artificial intelligence and machine learning (AI/ML) approaches to study sa …
INTRODUCTION: Artificial Intelligence Ready and Equitable for Diabetes Insights (AI-READI) is a data collection project on type 2
Continuous Glucose Monitoring in Hospitalized Adults With Diabetic Ketoacidosis: A Prospective Open-Label Pilot Study.
Bogun MM, Wang C, Kurlansky PA, Bedeir N, Umpierrez GE. Bogun MM, et al. J Diabetes Sci Technol. 2025 Feb 5:19322968251316887. doi: 10.1177/19322968251316887. Online ahead of print. J Diabetes Sci Technol. 2025. PMID: 39907056 Free PMC article.
BACKGROUND: Continuous glucose monitoring (CGM) devices are increasingly used in critical and non-critical care hospital units. ...RESULTS: We recruited 52 patients (49 19 years, admission glucose: 503 239.4 mg/dL) with type 1 diabetes (n = 24) and type
BACKGROUND: Continuous glucose monitoring (CGM) devices are increasingly used in critical and non-critical care hospita …
Effect of iGlarLixi on continuous glucose monitoring-measured time in range in insulin-naive adults with suboptimally controlled type 2 diabetes.
Frías JP, Ratzki-Leewing A, Dex T, Meneghini L, Rodrigues A, Shah VN. Frías JP, et al. Diabetes Obes Metab. 2025 Feb 4. doi: 10.1111/dom.16214. Online ahead of print. Diabetes Obes Metab. 2025. PMID: 39905643
AIMS: People with type 2 diabetes (T2D) and glycated haemoglobin (HbA1c) 9% may benefit from fixed-ratio combination therapies such as iGlarLixi (insulin glargine 100 U/mL and lixisenatide 33 mug/mL). Use of continuous glucose monitoring (CGM) i …
AIMS: People with type 2 diabetes (T2D) and glycated haemoglobin (HbA1c) 9% may benefit from fixed-ratio combination therapies …
Acute effects of a single bout structured resistance and combined exercise on blood glucose profile during exercise in patients with type 2 diabetes and healthy adults: A randomized crossover study.
Huang YM, Liu Z, Fu J, Shan PF, Wang J, Wen X. Huang YM, et al. Diabetes Res Clin Pract. 2025 Feb 2;221:112031. doi: 10.1016/j.diabres.2025.112031. Online ahead of print. Diabetes Res Clin Pract. 2025. PMID: 39904458
METHODS: Three trials were conducted: trial A examined aerobic, resistance, and combined exercise; trials B and C focused on three intensities of resistance and combined exercise. Participants including patients with type 2 diabetes and healthy adults completed a ra …
METHODS: Three trials were conducted: trial A examined aerobic, resistance, and combined exercise; trials B and C focused on three intensiti …
Insulin Pen Administration Efficacy and Safety in an Older Patient.
Montgomery DK, Shin TR, Newell BJ. Montgomery DK, et al. Sr Care Pharm. 2025 Feb 1;40(2):64-71. doi: 10.4140/TCP.n.2025.64. Sr Care Pharm. 2025. PMID: 39891326
Objective To describe a successful pharmacist-led intervention to effectively and safely provide education and pharmacotherapy management for an older patient with uncontrolled type 2 diabetes mellitus (T2DM) who failed to remove the needle shield on insulin pens fo …
Objective To describe a successful pharmacist-led intervention to effectively and safely provide education and pharmacotherapy management fo …
2,365 results